You are here

News

May 12, 2014
The Important and Varied Role of Nurses in HIV Research

Nurses play an integral role on the research team of HIV studies and vaccine clinical trials. In honor of International Nurses Day, held annually in May, we take a moment to profile two hard-working nurses who are helping in the quest to find an end to AIDS.

The Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok is a critical partner to the U.S. military’s HIV...

April 25, 2014
How the Military is Engaged in the Battle Against Malaria

For the observance of World Malaria Day, MHRP is pleased to share this statement from Col. Rob Paris, director of the Military Malaria Research Program at the Walter Reed Army Institute of Research highlighting the U.S. military's role in malaria prevention, treatment and diagnostics. Malaria and HIV coinfections often coexist in many parts of the world and combined, malaria and HIV cause more...

March 26, 2014
TB and HIV: A Deadly Combinaton

“Tuberculosis is a major HIV co-infection that, frankly kills many of our patients,” says Maj. Julie Ake, M.D., Associate Director for Vaccine Research and African Cohort Study Protocol Chair. “The TB and HIV epidemics together are really a perfect storm for causing morbidity and mortality in individuals who are affected by HIV. Historically, limitations in TB diagnostics have been challenging...

March 19, 2014
New Studies Enhance Knowledge of Antibodies in HIV Vaccine Trials

Two studies in the March 19 issue of Science Translational Medicine shed new light on the antibodies that appear to have played a role in decreasing the risk of HIV infection in the RV144 HIV vaccine trial. The results provide a better understanding of the immune response a vaccine may need to elicit in order to provide protection from HIV.

In a previous analysis of RV144 results,...

February 26, 2014
MHRP at CROI 2014

MHRP and collaborators gave the following presentations at the annual Conference on Retroviruses and Opportunistic Infections (CROI) that took place March 3–6 in Boston: 

Tuesday, March 4 Loss of HIV Serological Markers Following Early Treatment of Acute HIV Infection  –Mark Manak (MHRP) Poster 395, Session P-F3, 2:30 pm, Exhibit Hall A

Etravirine/Rilpivirine-Specific Mutations...

February 21, 2014
A Focus on Acute Infection Studies

The study of acute HIV infection is critical to the design and development of HIV vaccines and strategies to achieve an undetectable level of virus without antiretrovirals, or a functional cure. By diagnosing HIV within weeks or even days of infection, scientists are afforded the opportunity to study the early events following infection. This provides the opportunity to look at what the virus...

February 18, 2014
MHRP Diagnostics: A Unique Capability within the DoD

MHRP’s Department of Laboratory Diagnostics and Monitoring (DLDM) conducts state-of-the-art HIV and HIV-related infections diagnostics and cutting-edge diagnostic research. The diagnostics program boasts unique capabilities that aren’t replicated within the Department of Defense (DoD). The following is a Q&A with MHRP Diagnostics Chief, Sheila Peel, MSPH, Ph.D.

What is DLDM’s...

February 5, 2014
New study shows that antibodies seen in RV144 may also correlate with lower risk of infection from multiple HIV subtypes

In a study published in PloS One February 4, researchers show that vaccine-induced antibodies targeted at a particular region of the HIV virus, V1V2, correlate with reduced risk of infection but also react not just with the HIV subtype that was most commonly seen in RV144 (the Thai trial), but also with multiple HIV subtypes that circulate in other parts of the world.

This research was...

February 4, 2014
MHRP Welcomes Dr. Jintanat Ananworanich as Associate Director for Therapeutics Research

MHRP is pleased to announce that Dr. Jintanat Ananworanich has joined MHRP in a newly created position, as Associate Director for Therapeutics Research and member of MHRP’s leadership team.

Dr. Ananworanich will oversee adult HIV therapeutic trials as part of the newly-funded MHRP Clinical Trials Unit under the AIDS Clinical Trials Group (ACTG). She will play a critical role in the...

January 10, 2014
Former MHRP Leader Selected as Next U.S. Global AIDS Coordinator

The White House has nominated Dr. Deborah Birx to be the new U.S. Global AIDS Coordinator succeeding Dr. Eric Goosby who left the position in November. Reporting to the Secretary of State, Dr. Birx will coordinate and oversee the U.S. global response to HIV/AIDS, specifically the programs of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Prior to this nomination, Dr. Birx...

Pages